Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: a 10-year systematic literature review (SLR)
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: a 10-year systematic literature review (SLR) |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | Anota A, Pozet A, Lemasson H, Cotte F-E, Guerzider S, Mouillet G, Eberst G, Charton E, Westeel V |
| Journal | QUALITY OF LIFE RESEARCH |
| Volume | 29 |
| Pagination | S156 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 0962-9343 |